Positive GABA(A) receptor modulators from Acorus calamus and structural analysis of (+)-dioxosarcoguaiacol by 1D and 2D NMR and molecular modeling.

In a two-microelectrode voltage clamp with Xenopus laevis oocytes, a petroleum ether extract of Acorus calamus rhizomes enhanced the GABA-induced chloride current through GABA(A) receptors of the α₁β₂γ(2S) subtype by 277% ± 9.7% (100 μg/mL). β-Asarone (1), (+)-dioxosarcoguaiacol (2), (+)-shyobunone (3), and (+)-preisocalamenediol (4) were subsequently identified as main active principles through HPLC-based activity profiling and targeted isolation. The compounds induced maximum potentiation of the chloride current ranging from 588% ± 126% (EC₅₀: 65.3 ± 21.6 μM) (2) to 1200% ± 163% (EC(50): 171.5 ± 34.6 μM) (1), whereas (-)-isoshyobunone (5) and (-)-acorenone (6) exhibited weak GABA(A) modulating properties (5: 164% ± 42.9%; EC₅₀: 109.4 ± 46.6 μM and 6: 241% ± 23.1%; EC₅₀: 34.0 ± 6.7 μM). The relative configuration of 2 was established as 4R*8S*10R* by NOESY experiments and conformational analysis.

[1]  K. Vogt,et al.  GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts , 2009, Neuropharmacology.

[2]  B. Sakmann,et al.  Patch clamp measurements onXenopus laevis oocytes: currents through endogenous channels and implanted acetylcholine receptor and sodium channels , 1986, Pflügers Archiv.

[3]  G. Ecker,et al.  Valerenic acid derivatives as novel subunit‐selective GABAA receptor ligands –in vitro and in vivo characterization , 2010, British journal of pharmacology.

[4]  G. C. Walker,et al.  Separation of the Hypnotic Potentiating Principles from the Essential Oil of Acorus calamus L. of Indian Origin by Liquid–Gas Chromatography , 1960, Nature.

[5]  M. Hamburger,et al.  HPLC-based activity profiling of Angelica pubescens roots for new positive GABAA receptor modulators in Xenopus oocytes. , 2011, Fitoterapia.

[6]  G. Schwenker,et al.  Preisocalamenediol, A Constituent of Schinus molle. , 1987, Planta Medica.

[7]  C. Gerhäuser,et al.  HPLC-based activity profiling of Salvia miltiorrhiza for MAO A and iNOS inhibitory activities. , 2004, Planta medica.

[8]  M. Menon,et al.  The mechanism of the tranquillizing action of asarone from Acorus calamus Linn. , 1967, The Journal of pharmacy and pharmacology.

[9]  S. Baldwin,et al.  Spiro[4.5]decanes by photoannelation. Total synthesis of (−)-acorenone , 1982 .

[10]  I. Baburin,et al.  HPLC-based activity profiling: discovery of piperine as a positive GABA(A) receptor modulator targeting a benzodiazepine-independent binding site. , 2010, Journal of natural products.

[11]  R. Macdonald,et al.  Pentobarbital and picrotoxin have reciprocal actions on single GABAA receptor channels , 1989, Neuroscience Letters.

[12]  Steffen Hering,et al.  HPLC-based activity profiling approach for the discovery of GABAA receptor ligands using an automated two microelectrode voltage clamp assay on Xenopus oocytes. , 2008, Planta medica.

[13]  Werner Sieghart,et al.  International Union of Pharmacology. LXX. Subtypes of γ-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update , 2008, Pharmacological Reviews.

[14]  I. Baburin,et al.  Valerenic acid potentiates and inhibits GABAA receptors: Molecular mechanism and subunit specificity , 2007, Neuropharmacology.

[15]  J. Solomon,et al.  ent-Clerodanes and other constituents from Bolivian Baccharis species , 1989 .

[16]  R. Olsen,et al.  GABAA receptors: Subtypes provide diversity of function and pharmacology , 2009, Neuropharmacology.

[17]  K. Keller,et al.  [Extraction of thermolabile compounds with supercritical gases.]. , 1983, Planta medica.

[18]  Das Pk,et al.  Investigations on the mechanism of potentiation of barbiturate hypnosis by hersaponin, acorus oil, reserpine and chlorpromazine. , 1962 .

[19]  A. Mitra,et al.  Constituents of Acorus calamus: Structure of Acoramone. Carbon-13 NMR Spectra of Cis- and Trans-Asarone , 1981 .

[20]  I. Baburin,et al.  Automated fast perfusion of Xenopus oocytes for drug screening , 2006, Pflügers Archiv.

[21]  G. Abel Chromosomenschädigende Wirkung von β-Asaron in menschlichen Lymphocyten , 1987 .

[22]  M. Baraldi,et al.  Sedative and hypothermic effects induced by β‐asarone, a main component of Acorus calamus , 1998 .

[23]  S. A. Shah,et al.  Central nervous system studies on an ethanol extract of Acorus calamus rhizomes. , 1990, Journal of ethnopharmacology.

[24]  Y. Hirata,et al.  Isolation and structures of three new sesquiterpenes , 1968 .

[25]  G. Mazza Gas chromatographic and mass spectrometric studies of the constituents of the rhizome of calamus , 1985 .

[26]  Reinhard Dengler,et al.  Kinetic analysis of the agonistic and blocking properties of pentobarbital on recombinant rat α1β2γ2S GABAA receptor channels , 2002 .

[27]  Matthias Hamburger,et al.  Natural products in drug discovery –concepts and approaches for tracking bioactivity , 2006 .

[28]  G. Bringmann,et al.  The Assignment of Absolute Stereostructures through Quantum Chemical Circular Dichroism Calculations , 2009 .

[29]  Y. Hirata,et al.  Sesquiterpenes from Acorus calamus L. , 1971 .

[30]  M. Menon,et al.  Effects of asarone and beta-asarone on conditioned responses, fighting behaviour and convulsions. , 1963, British journal of pharmacology and chemotherapy.

[31]  I. Baburin,et al.  HPLC-based activity profiling for GABAA receptor modulators from the traditional Chinese herbal drug Kushen (Sophora flavescens root) , 2011, Molecular Diversity.

[32]  medica PantResearth,et al.  Zur Klassifizierung handelsüblicher Kalmusdrogen , 1981 .

[33]  S. Yamamura,et al.  STEREOCHEMICAL STUDIES ON THE ELEMENE-TYPE SESQUITERPENES FROM ACORUS CALAMUS L. , 1977 .

[34]  P. Houghton,et al.  Acorus calamus.: Scientific Validation of Ayurvedic Tradition from Natural Resources , 2007 .

[35]  C. F. Chen,et al.  Central inhibitory effects of water extract of Acori graminei rhizoma in mice. , 1998, Journal of ethnopharmacology.

[36]  P. But,et al.  Pharmacology and applications of chinese materia medica , 1986 .

[37]  M. Hamburger,et al.  HPLC-based activity profiling for GABA(A) receptor modulators: a new dihydroisocoumarin from Haloxylon scoparium. , 2010, Journal of natural products.

[38]  K. Keller,et al.  [Composition of the essential oil from beta-Asarone free calamus.]. , 1983, Planta medica.

[39]  W. Kubelka “Teedrogen und Phytopharmaka” , 2011, Scientia Pharmaceutica.

[40]  P. Weyerstahl,et al.  Struktur und Geruch, V. Von Menthon zu Shyobunon – Änderung des Geruchs mit der Struktur , 1987 .

[41]  J. Daly,et al.  New sesquiterpenoids of sweet flag oil (Acorus calamus) , 1979 .

[42]  R. Brun,et al.  Antiplasmodial lanostanes from the Ganoderma lucidum mushroom. , 2010, Journal of natural products.

[43]  M. Hamburger,et al.  Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria. , 2001, Planta medica.

[44]  Eric A. Barnard,et al.  Analysis of the Set of GABAA Receptor Genes in the Human Genome* , 2004, Journal of Biological Chemistry.

[45]  K. Altmann,et al.  Highly Potent Modulation of GABAA Receptors by Valerenic Acid Derivatives , 2010, ChemMedChem.

[46]  W. Göggelmann,et al.  Mutagenicity testing of beta-asarone and commercial calamus drugs with Salmonella typhimurium. , 1983, Mutation research.

[47]  T. Motley The ethnobotany of sweet flag,acorus Calamus (Araceae) , 1994, Economic Botany.

[48]  C. Khare Indian Herbal Remedies , 2004, Springer Berlin Heidelberg.

[49]  G. Gemmecker,et al.  BI-32169, a bicyclic 19-peptide with strong glucagon receptor antagonist activity from Streptomyces sp. , 2004, Journal of natural products.

[50]  E. Williamson Major herbs of ayurveda , 2002 .

[51]  Geoffrey D. Brown,et al.  Photo-oxygenation of Phytol and the Structure Revision of Phytene-1,2-diol from Artemisia annua to Phytene-1-ol-2-Hydroperoxidek † , 2002 .

[52]  H. Wolf,et al.  Synthese von spiroverbindungen—V , 1977 .

[53]  W. Sieghart,et al.  Pharmacological Properties of GABAA Receptors Containing γ1 Subunits , 2006, Molecular Pharmacology.